Aon Unveils First Workforce-Focused Analysis on GLP-1s: Medications and Holistic Support Can Transform Workforce Health and Bend

  • Firm also sets new standard in employee health by combining GLP-1 medications and holistic support to drive adherence and sustainable outcomes for Aon's U.S. colleagues in collaboration with eMed CHICAGO , April 30, 2025 /PRNewswire/ -- Aon plc (NYSE: AON), a leading global professional services firm, today released findings from a multi-year study of U.S. commercial health claims data for more than 50 million commercially insured lives. The analysis highlights a significant opportunity to reduce healthcare costs for employers and enhance overall workforce health through a comprehensive obesity management program that includes GLP-1 medications.